Amy E. Moritz, Ph.D.
Affiliations: | 2011 | The University of North Dakota, Grand Forks, ND, United States |
Area:
BiochemistryGoogle:
"Amy Moritz"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| Roxanne A. Vaughan | grad student | 2011 | University of North Dakota | |
| (Post-translational regulation of the dopamine transporter.) | ||||
| David R. Sibley | post-doc | NIH (Neurotree) | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Sánchez-Soto M, Boldizsar NM, Schardien KA, et al. (2023) G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation. Biomolecules. 13 |
| Sibley DR, Nilson AN, Moritz AE, et al. (2023) Dopamine receptor divergence revealed using a common ligand. Trends in Pharmacological Sciences |
| Enriquez-Traba J, Yarur-Castillo HE, Flores RJ, et al. (2023) Dissociable control of motivation and reinforcement by distinct ventral striatal dopamine receptors. Biorxiv : the Preprint Server For Biology |
| Mayer FP, Stewart A, Varman DR, et al. (2023) Kappa Opioid Receptor Antagonism Rescues Genetic Perturbation of Dopamine Homeostasis: Molecular, Physiological and Behavioral Consequences. Biorxiv : the Preprint Server For Biology |
| Moritz AE, Madaras NS, Rankin ML, et al. (2023) Delineation of G Protein-Coupled Receptor Kinase Phosphorylation Sites within the D Dopamine Receptor and Their Roles in Modulating β-Arrestin Binding and Activation. International Journal of Molecular Sciences. 24 |
| Moritz AE, Bonifazi A, Guerrero AM, et al. (2020) Evidence for a stereoselective mechanism for bitopic activity by extended-length antagonists of the D3 dopamine receptor. Acs Chemical Neuroscience |
| Moritz AE, Free RB, Weiner WS, et al. (2020) Discovery, Optimization and Characterization of ML417: A Novel and Highly Selective D3 Dopamine Receptor Agonist. Journal of Medicinal Chemistry |
| Sanchez-Soto M, Verma RK, Willette BKA, et al. (2020) A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Science Signaling. 13 |
| Akano EO, Casazza JA, Dranchak P, et al. (2020) Development of a dopaminergic neurodegeneration assay using laser cytometry of Caenorhabditis elegans models of Parkinson’s disease The Faseb Journal. 34: 1-1 |
| Moritz AE, Inbody LR, Gandhi DM, et al. (2020) Structure‐Activity Relationships of a Negative Allosteric Modulator of the D3 Dopamine Receptor and Investigation of its Binding Site The Faseb Journal. 34: 1-1 |